ACM
AlphaCrest Capital Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-49,810
| Closed | -$1.28M | – | 257 |
|
|
2022
Q3 | $1.28M | Sell |
49,810
-10,608
| -18% | -$272K | 0.08% | 453 |
|
|
2022
Q2 | $1.44M | Sell |
60,418
-57,645
| -49% | -$1.37M | 0.07% | 494 |
|
|
2022
Q1 | $2.66M | Sell |
118,063
-11,794
| -9% | -$266K | 0.15% | 153 |
|
|
2021
Q4 | $2.57M | Buy |
129,857
+28,562
| +28% | +$565K | 0.1% | 301 |
|
|
2021
Q3 | $1.99M | Buy |
101,295
+64,048
| +172% | +$1.26M | 0.1% | 303 |
|
|
2021
Q2 | $819K | Sell |
37,247
-35,248
| -49% | -$775K | 0.04% | 755 |
|
|
2021
Q1 | $1.73M | Buy |
+72,495
| New | +$1.73M | 0.1% | 310 |
|
|
2020
Q3 | – | Sell |
-37,295
| Closed | -$627K | – | 1102 |
|
|
2020
Q2 | $627K | Buy |
+37,295
| New | +$627K | 0.1% | 298 |
|
|
2020
Q1 | – | Sell |
-30,600
| Closed | -$370K | – | 1056 |
|
|
2019
Q4 | $370K | Sell |
30,600
-56,500
| -65% | -$683K | 0.03% | 955 |
|
|
2019
Q3 | $1.23M | Buy |
87,100
+58,100
| +200% | +$821K | 0.07% | 458 |
|
|
2019
Q2 | $323K | Sell |
29,000
-41,400
| -59% | -$461K | 0.03% | 841 |
|
|
2019
Q1 | $826K | Buy |
70,400
+50,900
| +261% | +$597K | 0.13% | 259 |
|
|
2018
Q4 | $261K | Buy |
+19,500
| New | +$261K | 0.08% | 508 |
|